Given that OPG treatment inhibited the RANKL-dependent upregulation of NF-κB transcriptional activity, integrin α2 expression, and subsequent cell adhesion, RANKL may function, at least in part, in a paracrine/autocrine manner via RANK in HNSCC. The gene discussed is TNFRSF11A; the disease is head and neck squamous cell carcinoma.